http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60197621-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2f96ed8637c48cd654855cc82cbcea7
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 1984-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f50e79b0502baeb7f606ecfb40c69607
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c7536cc4a34bb4e5e28289c655984c
publicationDate 1985-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S60197621-A
titleOfInvention Hypocholesterolemic
abstract PURPOSE: A hypocholesterolemic containing δ-tocopherol as an active ingredient. n CONSTITUTION: The objective hypocholesterolemic is obtained by using an effective amount of δ-tocopherol (a tocopherol mixture in which the concentration has been increased more than 50% in composition proportion, containing α-, β-, γ-, δ-tocopherols), when needed additionally an appropriate carrier and diluents are combined. The drug reduced remarkably serum cholesterol and can be effectively used as a preventive for arteriosclerosis, hypertension, thrombosis, stenocardia, cerebral hemorrhage and myocardiac infarction. There is no axiety of side-effect and toxicity, because a kind of vitamin E is used as an active ingredient. n COPYRIGHT: (C)1985,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11680034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071030-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04368326-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188670-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11753435-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10105325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11021424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9314527-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9561243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9932286-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10703701-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10973761-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9447006-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0247680-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008531603-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981855-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8841342-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9168216-B2
priorityDate 1984-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409004472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92094

Total number of triples: 40.